Literature DB >> 9230784

Detection of Trypanosoma cruzi with the polymerase chain reaction and in situ hybridization in infected murine cardiac tissue.

J E Lane1, D Olivares-Villagomez, C L Vnencak-Jones, T L McCurley, C E Carter.   

Abstract

Chagas' disease is caused by the hemoflagellate protozoan Trypanosoma cruzi, which is predominantly found in South and Central America and Mexico. Although the parasite is present in the United States, confirmed cases of human disease are rare. The most serious manifestation of chronic Chagas' disease is a progressive inflammatory cardiomyopathy. However, T. cruzi has not been consistently demonstrated with histologic techniques in inflammatory cardiac lesions. In this study, we used both polymerase chain reaction (PCR) amplification of extracted DNA from hematoxylin and eosin-stained tissue scrapings, and in situ hybridization to detect the presence of T. cruzi in infected murine cardiac tissue sections. Three T. cruzi-specific DNA sequences were used: a 122-basepair (bp) sequence localized within the minicircle network (MCS), a 188-bp nuclear repetitive sequence (RS), and a 177-bp sequence within the open reading frame of a gene coding for a flagellar protein (FPS). We found that all three sequences are amplifiable from scrapings of murine cardiac tissue. The MCS and RS are detected at 0.167 and 0.24 amastigote DNA equivalents, while FPS is barely detected at 0.24 amastigote DNA equivalents. On the other hand, in situ hybridization with all three sequences allowed for the detection of T. cruzi amastigotes within the tissue. The MCS and FPS, however, consistently yielded a more intense signal. These results indicate that PCR and in situ hybridization may prove useful in establishing the prevalence of T. cruzi in human chagasic cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9230784     DOI: 10.4269/ajtmh.1997.56.588

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  9 in total

1.  Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi.

Authors:  Silvia I Cazorla; Pablo D Becker; Fernanda M Frank; Thomas Ebensen; María J Sartori; Ricardo S Corral; Emilio L Malchiodi; Carlos A Guzmán
Journal:  Infect Immun       Date:  2007-10-29       Impact factor: 3.441

2.  Cornea as a tissue reservoir of Trypanosoma cruzi.

Authors:  Leidi Herrera; Clara Martínez; Hernán Carrasco; Ana Maria Jansen; Servio Urdaneta-Morales
Journal:  Parasitol Res       Date:  2006-12-20       Impact factor: 2.289

3.  Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection.

Authors:  B Wizel; N Garg; R L Tarleton
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

Review 4.  Susceptibility Testing of Medically Important Parasites.

Authors:  Abebe Genetu Bayih; Anjan Debnath; Edward Mitre; Christopher D Huston; Benoît Laleu; Didier Leroy; Benjamin Blasco; Brice Campo; Timothy N C Wells; Paul A Willis; Peter Sjö; Wesley C Van Voorhis; Dylan R Pillai
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

5.  Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses.

Authors:  B Wizel; M Palmieri; C Mendoza; B Arana; J Sidney; A Sette; R Tarleton
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

6.  Bioluminescent imaging of Trypanosoma cruzi infection.

Authors:  Kenneth V Hyland; Sofya H Asfaw; Cheryl L Olson; Melvin D Daniels; David M Engman
Journal:  Int J Parasitol       Date:  2008-04-25       Impact factor: 3.981

7.  Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice.

Authors:  Anita R Schnapp; Chris S Eickhoff; Donata Sizemore; Roy Curtiss; Daniel F Hoft
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

8.  Development of chemiluminescent lateral flow assay for the detection of nucleic acids.

Authors:  Yuhong Wang; Catherine Fill; Sam R Nugen
Journal:  Biosensors (Basel)       Date:  2012-01-18

9.  Trypanosoma cruzi Entrance through Systemic or Mucosal Infection Sites Differentially Modulates Regional Immune Response Following Acute Infection in Mice.

Authors:  Juliana de Meis; Juliana Barreto de Albuquerque; Danielle Silva Dos Santos; Désio Aurélio Farias-de-Oliveira; Luiz Ricardo Berbert; Vinícius Cotta-de-Almeida; Wilson Savino
Journal:  Front Immunol       Date:  2013-07-26       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.